| Accession Number: | 0001493152-21-025084 |
| Date: | 2021-10-05 |
| Issuer: | ABEONA THERAPEUTICS INC. (ABEO) |
| Original Submission Date: |
O'MALLEY BRENDAN M.
1330 AVENUE OF THE AMERICAS, 33RD FLOOR
NEW YORK, NY 10019
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | 2021-10-05 | S | 2,447 | d | $1.05 | 271,007 | direct | ||
| COMMON STOCK | 2021-10-08 | S | 22,763 | d | $1.05 | 248,244 | direct |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|
| ID | footnote |
|---|---|
| f1 | the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by brendan o'malley on february 24, 2021. |
| f2 | the price reported in column 4 is a weighted average price. the shares were sold in multiple transactions at prices ranging from $0.84 to $1.12, inclusive. the reporting person undertakes to provide to the issuer, any security holder, or the staff of the sec, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote. |
